18F-Fluorodeoxyglucose Positron Emission Tomography in Elderly Patients with an Elevated Erythrocyte Sedimentation Rate of Unknown Origin

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lensen, Karel Jan D F ^a   Voskuyl, Alexandre E ^b   van der Laken, Conny J ^b   Comans, Emile F I ^b   van Schaardenburg, Dirkjan ^c   Arntzenius, Alex B ^d   Zwijnenburg, Ton ^d   Stam, Frank ^e   Gompelman, Michelle ^e   Zant, Friso M v d ^e   van Paassen, Anneke Q A ^f   Voerman, Bert J ^g   Smit, Frits ^h   Anten, Sander ^h   Siegert, Carl E ⁱ   Binnerts, Arjen ^j   Smulders, Yvo M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JAN VAN BREEMEN INSTITUTE   (Netherlands)

^d Department of Orthopaedic Surgery   (Netherlands)

^e Medical Centre Alkmaar   (Netherlands)

^f Kennemer Gasthuis ^*  (Netherlands)

^g AMSTELLAND HOSPITAL   (Netherlands)

^h RIJNLAND HOSPITAL   (Netherlands)

ⁱ ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^j ZAANS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTERITIS; ARTHRITIS; ARTICLE; AUTOINFLAMMATORY DISEASE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RADIATION DOSE; RETROSPECTIVE STUDY; STOMACH CANCER; TENDINITIS; TICK BORNE DISEASE;

AGED; AGED, 80 AND OVER; BLOOD SEDIMENTATION; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84875092953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058917     Document Type: Article

References (38)

1. Cankurtaran M, Ulger Z, Halil M, Yavuz BB, Onal IK, et al. (2009) How to assess high erythrocyte sedimentation rate (ESR) in elderly? Arch Gerontol Geriatr.
2. Saadeh C, (1998) The erythrocyte sedimentation rate: old and new clinical applications. South Med J 91: 220-225.
3. Wyler DJ, (1977) Diagnostic implications of markedly elevated erythrocyte sedimentation rate: a reevaluation. South Med J 70: 1428-1430.
4. Townsend DW, (2008) Positron emission tomography/computed tomography. Semin Nucl Med 38: 152-166.
5. Balink H, Collins J, Bruyn G, Gemmel F, (2009) F-18 FDG PET/CT in the Diagnosis of Fever of Unknown Origin. Clin Nucl Med 34: 862-868.
6. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, et al. (2007) A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore) 86: 26-38.
7. Jaruskova M, Belohlavek O, (2006) Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 33: 913-918.
8. Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D, (2004) Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 15: 151-156.
9. Lorenzen J, Buchert R, Bohuslavizki KH, (2001) Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 22: 779-783.
10. Vanderschueren S, Del Biondo E, Ruttens D, Van Boxelaer I, Wauters E, et al. (2009) Inflammation of unknown origin versus fever of unknown origin: two of a kind. Eur J Intern Med 20: 415-418.
11. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, et al. (2011) The impact of (18)F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 39: 344-353.
12. Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, et al. (2008) The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35: 2320-2333.
13. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM, (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42: 311-317.
14. Janssen SP, Comans EH, Voskuyl AE, Wisselink W, Smulders YM, (2008) Giant cell arteritis: Heterogeneity in clinical presentation and imaging results. J Vasc Surg 48: 1025-1031.
15. Younge BR, Cook BE Jr, Bartley GB, Hodge DO, Hunder GG, (2004) Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc 79: 483-491.
16. Rosenbaum J, Basu S, Beckerman S, Werner T, Torigian DA, et al. (2011) Evaluation of diagnostic performance of 18F-FDG-PET compared to CT in detecting potential causes of fever of unknown origin in an academic centre. Hell J Nucl Med 14: 255-259.
17. Keidar Z, Gurman-Balbir A, Gaitini D, Israel O, (2008) Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med 49: 1980-1985.
18. Sheng JF, Sheng ZK, Shen XM, Bi S, Li JJ, et al. (2011) Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Eur J Intern Med 22: 112-116.
19. Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, et al. (2010) Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract 64: 55-60.
20. Blockmans D, Stroobants S, Maes A, Mortelmans L, (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108: 246-249.
21. Gerber NJ, (1984) Giant cell arteritis and its variants. Eur Neurol 23: 410-420.
22. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL, (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48: 3522-3531.
23. Bley TA, Wieben O, Uhl M, Miehle N, et al. (2005) Integrated head-thoracic vascular MRI at 3 T: assessment of cranial, cervical and thoracic involvement of giant cell arteritis. MAGMA 18: 193-200.
24. Markl M, Uhl M, Wieben O, Ness T, Langer M, et al. (2006) High resolution 3T MRI for the assessment of cervical and superficial cranial arteries in giant cell arteritis. J Magn Reson Imaging 24: 423-427.
25. Narvaez J, Narvaez JA, Nolla JM, Sirvent E, Reina D, et al. (2005) Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) 44: 479-483.
26. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, et al. (2012) Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 71: 1170-1176.
27. Besson FL, Parienti JJ, Bienvenu B, Prior JO, Costo S, et al. (2011) Diagnostic performance of (1)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 38: 1764-1772.
28. Lie JT, (1995) Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 24: 422-431.
29. Ostberg G (1973) An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand Suppl 237: Suppl 59.
30. Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, et al. (2011) FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med 25: 355-364.
31. Shusterman N, Kimmel PL, Kiechle FL, Williams S, Morrison G, et al. (1985) Factors influencing erythrocyte sedimentation in patients with chronic renal failure. Arch Intern Med 145: 1796-1799.
32. Mourad O, Palda V, Detsky AS, (2003) A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163: 545-551.
33. Wagner AD, Andresen J, Raum E, Lotz J, Zeidler H, et al. (2005) Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis. Ann Rheum Dis 64: 105-110.
34. Rosenbaum J, Basu S, Beckerman S, Werner T, Torigian DA, et al. (2011) Evaluation of diagnostic performance of 18F-FDG-PET compared to CT in detecting potential causes of fever of unknown origin in an academic centre. Hell J Nucl Med 14: 255-259.
35. Bleeker-Rovers CP, van der Meer JW, Oyen WJ, (2009) Fever of unknown origin. Semin Nucl Med 39: 81-87.
36. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33: 1122-1128.
37. Belhocine T, (2004) 18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET. Eur J Nucl Med Mol Imaging 31: 1055-1056.
38. Henes JC, Muller M, Krieger J, Balletshofer B, Pfannenberg AC, et al. (2008) [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 26: S47-S52.